Cargando…
SIRT6, a novel direct transcriptional target of FoxO3a, mediates colon cancer therapy
SIRT6, NAD+-dependent deacetylase sirtuin 6, has recently shown to suppress tumor growth in several types of cancer. Colon cancer is a challenging carcinoma associated with high morbidity and death. However, whether SIRT6 play a direct role in colon tumorigenesis and the underlying mechanism are not...
Autores principales: | Zhang, Yingjie, Nie, Liming, Xu, Keqian, Fu, Yang, Zhong, Juchang, Gu, Kongzhen, Zhang, Lingling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531295/ https://www.ncbi.nlm.nih.gov/pubmed/31149050 http://dx.doi.org/10.7150/thno.29724 |
Ejemplares similares
-
Targeting the core of neurodegeneration: FoxO, mTOR, and SIRT1
por: Maiese, Kenneth
Publicado: (2020) -
Redox regulation of FoxO transcription factors
por: Klotz, Lars-Oliver, et al.
Publicado: (2015) -
FoxO transcription factors in mitochondrial homeostasis
por: Cheng, Zhiyong
Publicado: (2022) -
Ipatasertib, a novel Akt inhibitor, induces transcription factor FoxO3a and NF-κB directly regulates PUMA-dependent apoptosis
por: Sun, Li, et al.
Publicado: (2018) -
Polymerase independent repression of FoxO1 transcription by sequence-specific PARP1 binding to FoxO1 promoter
por: Tian, Yu-Nan, et al.
Publicado: (2020)